Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01109069
Title Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pharmacyclics LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Stanford California 94305 United States Details
Stanford California 94305 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Boston Massachusetts 02215 United States Details
New Hyde Park New York 11042 United States Details
New York New York 10065 United States Details
Rochester New York 14642-0001 United States Details
Columbus Ohio 43210 United States Details
Springfield Oregon 97477 United States Details
Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Houston Texas 77030 United States Details
Tyler Texas 75702 United States Details
Fletcher Allen Health Care and University of Vermont Burlington Vermont 05405 United States Details
Vancouver Washington 98684 United States Details
Yakima Valley Memorial Hospital/North Star Lodge Yakima Washington 98902 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field